---
title: "12 Health Care Stocks Moving In Monday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299640743.md"
description: "In Monday's pre-market session, several healthcare stocks showed significant movement. Greenland Mines surged 108.1% to $5.93, while Cue Biopharma rose 32.25% to $49.0. Other gainers included DataMEDS AI, Scinai Immunotherapeutics, Lakewood-Amedex, and Invivyd. Conversely, IM Cannabis dropped 30.3% to $2.95, with Aligos Therapeutics, Intelligent Bio Solutions, BeyondSpring, Palatin Techs, and Telix Pharmaceuticals also declining."
datetime: "2026-09-21T12:06:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299640743.md)
  - [en](https://longbridge.com/en/news/299640743.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299640743.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's Pre-Market Session

### Gainers

-   **Greenland Mines** (NASDAQ:GRML) stock rose 108.1% to $5.93 during Monday's pre-market session. The market value of their outstanding shares is at $9.0 million.
-   **Cue Biopharma** (NASDAQ:CUE) stock moved upwards by 32.25% to $49.0. The company's market cap stands at $269.1 million.
-   **DataMEDS AI** (NASDAQ:MEDS) shares moved upwards by 12.76% to $4.24. The market value of their outstanding shares is at $12.0 million.
-   **Scinai Immunotherapeutics** (NASDAQ:SCNI) stock moved upwards by 11.53% to $1.74. The market value of their outstanding shares is at $1.0 million.
-   **Lakewood-Amedex** (NASDAQ:LABT) shares moved upwards by 11.05% to $2.21. The market value of their outstanding shares is at $4.7 million.
-   **Invivyd** (NASDAQ:IVVD) stock moved upwards by 10.73% to $0.84. The market value of their outstanding shares is at $222.5 million.

### Losers

-   **IM Cannabis** (NASDAQ:IMCC) shares decreased by 30.3% to $2.95 during Monday's pre-market session. The company's market cap stands at $2.5 million.
-   **Aligos Therapeutics** (NASDAQ:ALGS) stock decreased by 15.08% to $4.45. The company's market cap stands at $32.7 million.
-   **Intelligent Bio Solutions** (NASDAQ:INBS) stock decreased by 13.84% to $1.68. The company's market cap stands at $6.4 million.
-   **BeyondSpring** (NASDAQ:BYSI) stock declined by 13.05% to $0.65. The market value of their outstanding shares is at $30.8 million.
-   **Palatin Techs** (NASDAQ:PTN) shares decreased by 12.53% to $9.5. The market value of their outstanding shares is at $19.3 million.
-   **Telix Pharmaceuticals** (NASDAQ:TLX) stock decreased by 9.46% to $11.4. The market value of their outstanding shares is at $4.2 billion. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BYSI.US](https://longbridge.com/en/quote/BYSI.US.md)
- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)
- [IVVD.US](https://longbridge.com/en/quote/IVVD.US.md)
- [INBS.US](https://longbridge.com/en/quote/INBS.US.md)
- [PTN.US](https://longbridge.com/en/quote/PTN.US.md)
- [SCNI.US](https://longbridge.com/en/quote/SCNI.US.md)
- [LABT.US](https://longbridge.com/en/quote/LABT.US.md)
- [ALGS.US](https://longbridge.com/en/quote/ALGS.US.md)
- [IMCC.US](https://longbridge.com/en/quote/IMCC.US.md)
- [CUE.US](https://longbridge.com/en/quote/CUE.US.md)
- [GRML.US](https://longbridge.com/en/quote/GRML.US.md)
- [MEDS.US](https://longbridge.com/en/quote/MEDS.US.md)
- [GRMLW.US](https://longbridge.com/en/quote/GRMLW.US.md)
- [PTNTD.US](https://longbridge.com/en/quote/PTNTD.US.md)
- [PTNT.US](https://longbridge.com/en/quote/PTNT.US.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)

## Related News & Research

- [Scinai Immunotherapeutics Extends Cash Runway on New CDMO Deal and October Financing](https://longbridge.com/en/news/302438355.md)
- [Scinai Immunotherapeutics Ltd. (SCNI) Secures $5.1M CDMO Work, Runway to Late 2027](https://longbridge.com/en/news/302424934.md)
- [BeyondSpring Presents Plans for 442-Patient Phase 3 Plinabulin Trial in Post-ICI Lung Cancer](https://longbridge.com/en/news/303019482.md)
- [Telix Pharmaceuticals Limited (TLX) Issues Q3 Update, Reaffirms 2026 PM Growth Target](https://longbridge.com/en/news/302474055.md)
- [BUZZ-Citi puts Australia's Telix on positive catalyst watch of Zircaix FDA filing](https://longbridge.com/en/news/303139466.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**